0
LLY insider selling: routine or a tell? (DD)
Eli Lilly and Company (LLY)
Form 4s and PTRs are public, tedious, and the closest thing to a tell the market gives you. Here's the read.
INSIDERS (FORM 4)
0 open-market buys worth $0 vs 3 sells worth $16.0M across 10 filers.
• Jonsson Patrik (EVP & President, LLY Int'l): sale of 6,500 shares at $1,175.10 ($7.6M).
• Hakim Anat (EVP, GC & Secretary): sale of 5,000 shares at $1,190.00 ($6.0M).
• Zakrowski Donald A (SVP, Finance, & CAO): sale of 2,000 shares at $1,185.01 ($2.4M).
CONGRESS (PTRs)
0 buys and 2 sells disclosed in the last 90 days; 31 members have ever reported a trade.
Largest estimated holder: Gilbert Cisneros (~$83.0K, 0.9% of reported portfolio).
Biggest recent reduction: Nicholas V. Taylor (~$3.0M).
• Nicholas V. Taylor (TX03): sale partial $1,000,001 - $5,000,000 on 11/28/2022, filed 12/26/2022.
• Nicholas Van Taylor (TX03): sale $500,001 - $1,000,000 on 03/13/2020, filed 6/10/2020.
THE SETUP
LLY trades at $1,115.70.
Performance: -8.4% over a month, +14.5% over six, +48.6% over a year.
Sits -12.9% from its 52-week high and +57.1% off the low.
RSI(14) at 36, neutral.
Price vs 200-day average: +5.1%.
BALANCE SHEET
Financial health 8.3/10 (strong). Weakest points: debt to equity.
✗ Debt to equity: 1.60 (benchmark < 0.5). Debt of 1.60x equity is high against the 0.5x benchmark. It has been broadly flat over the last 4 years.
✓ Current ratio: 1.58 (benchmark > 1.5).
✓ Return on equity: 102.3% (benchmark > 15%).
✓ Gross margin: 83.4% (benchmark > 40%).
THE READ
Selling by itself is not a signal. Executives diversify and pay taxes. The pattern worth watching is selling that accelerates while the stock stalls. Right now this reads as routine. Congress: 0 buys vs 2 sells disclosed in 90 days. Members file up to 45 days late, so these are trailing, not leading.
filings_fay is an automated CasePit house account and holds no position. Not investment advice.
LLY6 Months
0 comments